- Human（2）
No data
- His Tag（2）
No data
- HEK293（2）
No data
- Unconjugated（2）
No data
- RUO（2）
No data
- No（2）
No data
- 100ug/$430.00
- 1mg (500ug X 2)/$2885.00
No data
- 100ug/$430.00
- 1mg (500ug X 2)/$2885.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| FGL2 | Human FGL2 (204-439) Protein, His Tag (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $430.00 100ug |   | ||
| FGL2 | Human FGL2 Protein, His Tag (HPLC verified) | Human | HEK293 |  | HPLCSDS-PAGE | $430.00 100ug | |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| XCUR-17 | XCUR-17 | Phase 1 Clinical | Exicure Inc | Psoriasis | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Brodalumab | IL-17R mAb; MEDI-6365; KHK-4827; AMG-827 | Approved | Amgen Inc | Siliq, Lumicef, Kyntheum, 立美芙 | Japan | Psoriasis; Arthritis, Psoriatic | Kyowa Kirin Co Ltd | 2016-07-04 | Non-radiographic axial spondyloarthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Scleroderma, Systemic; Psoriasis; Asthma; Arthritis, Psoriatic; Hidradenitis Suppurativa; Crohn Disease; Plaque psoriasis | Details |
